Insights into molecular therapy of glioma: current challenges and next generation blueprint
about
Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.
P2860
Insights into molecular therapy of glioma: current challenges and next generation blueprint
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Insights into molecular therap ...... and next generation blueprint
@en
Insights into molecular therap ...... and next generation blueprint.
@nl
type
label
Insights into molecular therap ...... and next generation blueprint
@en
Insights into molecular therap ...... and next generation blueprint.
@nl
prefLabel
Insights into molecular therap ...... and next generation blueprint
@en
Insights into molecular therap ...... and next generation blueprint.
@nl
P2093
P2860
P356
P1476
Insights into molecular therap ...... and next generation blueprint
@en
P2093
Ahona Mukherjee
Goutam Dey
Ipsita Pal
Payel Banik
Sachin A Borkar
Sandipan Chakraborty
P2860
P2888
P304
P356
10.1038/APS.2016.167
P50
P577
2017-03-20T00:00:00Z